Derivative Liabilities (Details)	3 Months Ended
Derivative Liabilities (Details)	May 31, 2017 $ / shares
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Market value of common stock on measurement date	$ 0.14
Expected dividend yields	0.00%
Maximum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Exercise price	$ 1.50
Risk free interest rate	1.75%
Expected term in years	4 years 9 months 18 days
Expected volatility	213.00%
Minimum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Exercise price	$ 0.08
Risk free interest rate	1.17%
Expected term in years	9 months 18 days
Expected volatility	171.00%
Initial Valuation [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Market value of common stock on measurement date	$ 0.17
Expected dividend yields	0.00%
Initial Valuation [Member] \| Maximum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Exercise price	$ 1.50
Risk free interest rate	2.08%
Expected term in years	4 years
Expected volatility	168.00%
Initial Valuation [Member] \| Minimum [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Exercise price	$ 0.09
Risk free interest rate	1.03%
Expected term in years	1 year
Expected volatility	153.00%

NEXUS BIOPHARMA INC 10-Q